{"url_path":"/sec/grve/10-k/2026/cover-page","section_key":"cover-page","section_title":"Cover Page","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-29","source_url":"https://www.sec.gov/Archives/edgar/data/918573/0001477932-26-004080-index.html","accession_number":"0001477932-26-004080","cik":"0000918573","ticker":"GRVE","issuer_name":"GROOVE BOTANICALS INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/918573/0001477932-26-004080-index.html","primary_entity_key":"0000918573","primary_entity_name":"GROOVE BOTANICALS INC."},"word_count":1330,"has_tables":true,"body_markdown":"grve_10k.htm\n0000918573false--03-31FY20260.100.1010020001001983100100198319830.001200000000596430625964306259643062falsefalsefalsefalse33195400003319517847000009185732025-04-012026-03-310000918573grve:LeaseAgreementMember2025-04-012026-03-310000918573grve:KentRodriguezMemberus-gaap:SeriesBPreferredStockMember2025-03-310000918573us-gaap:SeriesBPreferredStockMember2024-04-012025-03-310000918573us-gaap:SeriesBPreferredStockMember2025-04-012026-03-310000918573grve:AuthorizedToIssuedMember2026-03-310000918573us-gaap:SeriesAPreferredStockMember2024-04-012025-03-310000918573grve:KentRodriguezMemberus-gaap:SeriesBPreferredStockMember2026-03-310000918573us-gaap:SeriesAPreferredStockMember2025-04-012026-03-310000918573grve:KentRodriguezMemberus-gaap:SeriesBPreferredStockMember2024-04-012025-03-310000918573grve:KentRodriguezMemberus-gaap:SeriesBPreferredStockMember2025-04-012026-03-310000918573us-gaap:SeriesAPreferredStockMember2024-07-012024-07-300000918573us-gaap:RetainedEarningsMember2026-03-310000918573us-gaap:AdditionalPaidInCapitalMember2026-03-310000918573us-gaap:CommonStockMember2026-03-310000918573grve:PreferredStockSeriesBStockMember2026-03-310000918573grve:PreferredStockSeriesAStockMember2026-03-310000918573us-gaap:RetainedEarningsMember2025-04-012026-03-310000918573us-gaap:AdditionalPaidInCapitalMember2025-04-012026-03-310000918573us-gaap:CommonStockMember2025-04-012026-03-310000918573grve:PreferredStockSeriesBStockMember2025-04-012026-03-310000918573grve:PreferredStockSeriesAStockMember2025-04-012026-03-310000918573us-gaap:RetainedEarningsMember2025-03-310000918573us-gaap:AdditionalPaidInCapitalMember2025-03-310000918573us-gaap:CommonStockMember2025-03-310000918573grve:PreferredStockSeriesBStockMember2025-03-310000918573grve:PreferredStockSeriesAStockMember2025-03-310000918573us-gaap:RetainedEarningsMember2024-04-012025-03-310000918573us-gaap:AdditionalPaidInCapitalMember2024-04-012025-03-310000918573us-gaap:CommonStockMember2024-04-012025-03-310000918573grve:PreferredStockSeriesBStockMember2024-04-012025-03-310000918573grve:PreferredStockSeriesAStockMember2024-04-012025-03-3100009185732024-03-310000918573us-gaap:RetainedEarningsMember2024-03-310000918573us-gaap:AdditionalPaidInCapitalMember2024-03-310000918573us-gaap:CommonStockMember2024-03-310000918573grve:PreferredStockSeriesBStockMember2024-03-310000918573grve:PreferredStockSeriesAStockMember2024-03-3100009185732024-04-012025-03-310000918573us-gaap:SeriesBPreferredStockMember2025-03-310000918573us-gaap:SeriesBPreferredStockMember2026-03-310000918573us-gaap:SeriesAPreferredStockMember2025-03-310000918573us-gaap:SeriesAPreferredStockMember2026-03-3100009185732025-03-3100009185732026-03-3100009185732026-06-2500009185732025-09-30iso4217:USDxbrli:sharesiso4217:USDxbrli:sharesxbrli:pure\n\n \n\n**UNITED STATES**\n\n**SECURITIES AND EXCHANGE COMMISSION**\n\n**Washington, D.C. 20549**\n\n \n\n**FORM 10-K**\n\n \n\n(Mark One)\n\n \n\n☒\n\n**ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n \n\n \n\nFor the fiscal year ended **March 31, 2026**\n\n \n\n \n\n☐\n\n**TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934**\n\n \n\n \n\n \n\nFor the transition period from _______ to _______.\n\n \n\nCommission file number: **000-23476**\n\n \n\n**GROOVE BOTANICALS INC.**\n\n(Exact name of registrant as specified in its charter)\n\n \n\n**Nevada**\n\n \n\n**84-1168832**\n\n(State or other jurisdiction of\n\n \n\n(I.R.S. Employer\n\nincorporation or organization)\n\n \n\nIdentification No.)\n\n \n\nRegistrant’s Principal Office\n\n**310 Fourth Avenue South, Suite 7000**\n\n**Minneapolis, MN 55415** \n\n \n\nRegistrant’s telephone number, including area code:\n\n**(612-315-5068)**\n\n \n\n Securities registered pursuant to Section 12(b) of the Act:\n\n \n\nTitle of each class\n\n \n\nTrading Symbol(s)\n\n \n\nName of each exchange on which registered\n\nNone\n\n \n\nN/A\n\n \n\nN/A\n\n \n\nSecurities registered pursuant to Section 12(g) of the Act:\n\nCommon Stock, $0.001 par value\n\n \n\nIndicate by checkmark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐     No ☒\n\n \n\nIndicate by checkmark if the registrant is not required to file reports pursuant to Section 13 or 15(d) of the Act. Yes ☐    No ☒\n\n \n\nIndicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒     No ☐\n\n \n\nIndicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒     No ☐\n\n \n\nIndicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.\n\n \n\nLarge accelerated filer\n\n☐\n\nAccelerated filer\n\n☐\n\nNon-accelerated filer\n\n☒\n\nSmaller reporting company\n\n☒\n\nEmerging Growth Company\n\n☐\n\n \n\n \n\n \n\nIf an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Yes ☐     No ☐\n\n \n\nIndicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐\n\n \n\nIf securities are registered pursuant to Section 12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect the correction of an error to previously issued financial statements. ☐\n\n \n\nIndicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of the registrant’s executive officers during the relevant recovery period pursuant to § 240.10D-1(b). ☐\n\n \n\nIndicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐     No ☒\n\n \n\nThe aggregate market value of the registrant’s common stock, par value $0.001 per share (“Common Stock”), held by non-affiliates, computed by reference to the price at which the Common Stock was last sold as of September 30, 2025, the last business day of the registrant’s most recently completed second fiscal quarter, was approximately $304,174.\n\n \n\nThe number of shares of the registrant’s Common Stock outstanding as of June 25, 2026 was 59,643,062 shares.\n\n \n\nDOCUMENTS INCORPORATED BY REFERENCE\n\n \n\nList hereunder the following documents if incorporated by reference and the Part of the Form 10-K (e.g., Part I, Part II, etc.) into which the document is incorporated: (1) Any annual report to security holders; (2) Any proxy or information statement; and (3) Any prospectus filed pursuant to Rule 424(b) or (c) under the Securities Act of 1933. The listed documents should be clearly described for identification purposes (e.g., annual report to security holders for fiscal year ended December 24, 1980).\n\n \n\n**None**\n\n \n\n \n\n \n\n \n\n**TABLE OF CONTENTS**\n\n \n\n \n\n \n\n \n\n**Page** \n\n \n\n \n\n \n\n \n\n \n\n \n\n**PART I.**\n\n \n\n \n\n \n\n[Item 1.](#i1)\n\n[Business](#i1)\n\n \n\n3\n\n \n\n[Item 1A.](#i1a)\n\n[Risk Factors](#i1a)\n\n \n\n5\n\n \n\n[Item 1B.](#i1b)\n\n[Unresolved Staff Comments](#i1b)\n\n \n\n5\n\n \n\n[Item 1C](#i1c)\n\n[Cybersecurity](#i1c)\n\n \n\n5\n\n \n\n[Item 2.](#i2)\n\n[Properties](#i2)\n\n \n\n6\n\n \n\n[Item 3.](#i3)\n\n[Legal Proceedings](#i3)\n\n \n\n6\n\n \n\n[Item 4.](#i4)\n\n[Mine Safety Disclosures](#i4)\n\n \n\n6\n\n \n\n \n\n \n\n \n\n \n\n \n\n**PART II.**\n\n \n\n \n\n \n\n[Item 5.](#i5)\n\n[Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities](#i5)\n\n \n\n7\n\n \n\n[Item 6.](#i6)\n\n[Reserved](#i6)\n\n \n\n9\n\n \n\n[Item 7.](#i7)\n\n[Management’s Discussion and Analysis of Financial Condition and Results of Operations](#i7)\n\n \n\n9\n\n \n\n[Item 7A.](#i7a)\n\n[Quantitative and Qualitative Disclosures About Market Risk](#i7a)\n\n \n\n12\n\n \n\n[Item 8.](#i8)\n\n[Financial Statement and Supplementary Data](#i8)\n\n \n\n12\n\n \n\n[Item 9.](#i9)\n\n[Changes in and Disagreements with Accountants on Accounting and Financial Disclosure](#i9)\n\n \n\n12\n\n \n\n[Item 9A.](#i9a)\n\n[Controls and Procedures](#i9a)\n\n \n\n13\n\n \n\n[Item 9B.](#i9b)\n\n[Other Information](#i9b)\n\n \n\n14\n\n \n\n[Item 9C.](#i9c)\n\n[Disclosure Regarding Foreign Jurisdictions that Prevent Inspections](#i9c)\n\n \n\n14\n\n \n\n \n\n \n\n \n\n \n\n \n\n**PART III.**\n\n \n\n \n\n \n\n[Item 10.](#i10)\n\n[Directors, Executive Officers and Corporate Governance](#i10)\n\n \n\n15\n\n \n\n[Item 11.](#i11)\n\n[Executive Compensation](#i11)\n\n \n\n17\n\n \n\n[Item 12.](#i12)\n\n[Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters](#i12)\n\n \n\n17\n\n \n\n[Item 13.](#i13)\n\n[Certain Relationships and Related Transactions, and Director Independence](#i13)\n\n \n\n18\n\n \n\n[Item 14.](#i14)\n\n[Principal Accounting Fees and Services](#i14)\n\n \n\n19\n\n \n\n \n\n \n\n \n\n \n\n \n\n**PART IV.**\n\n \n\n \n\n \n\n[Item 15.](#i15)\n\n[Exhibits, Financial Statement Schedules](#i15)\n\n \n\n20\n\n \n\n[Item 16.](#i16)\n\n[Form 10-K Summary](#i16)\n\n \n\n34\n\n \n\n \n\n \n\n2\n\n*Table of Contents*\n\n \n\n**PART I**\n\n \n\n**Cautionary Note Regarding Forward-Looking Statements**\n\n \n\nIn addition to historical information, this Annual Report on Form 10-K of Groove Botanicals Inc. contains “forward-looking statements.” Any statements contained herein that are not statements of historical fact may be deemed to be forward-looking statements. In addition, any statements that refer to other characterizations of future events or circumstances, including any underlying assumptions, are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. These forward-looking statements involve significant risks and uncertainties that could cause the actual results to differ materially from the expected results and, consequently, you should not rely on these forward-looking statements as predictions of future events. These forward-looking statements and factors that may cause such differences include, without limitation, future capital requirements, regulatory actions or delays and other factors that may cause actual results to be materially different from those described or anticipated by these forward-looking statements. The foregoing list of factors is not exclusive. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. All forward-looking statements are based upon our current expectations and various assumptions. We believe there is a reasonable basis for our expectations and beliefs, but there can be no assurance that we will realize our expectations or that our beliefs will prove to be correct.\n\n \n\nThere may be other factors of which we are currently unaware or which we currently deem immaterial that may cause our actual results to differ materially from the forward-looking statements. All forward-looking statements attributable to us or persons acting on our behalf apply only as of the date they are made and are expressly qualified in their entirety by the cautionary statements included in this report. Except as may be required by law, we undertake no obligation to publicly update or revise any forward-looking statement to reflect events or circumstances occurring after the date they were made or to reflect the occurrence of unanticipated events, or otherwise."}